These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 6005102)
1. [Activity of the properdin system in patients with scleroma]. Izraitel' NA; Astapov AA Zh Ushn Nos Gorl Bolezn; 1966; 26(6):54-7. PubMed ID: 6005102 [No Abstract] [Full Text] [Related]
3. Scleroma (Rhinoscleroma). A histologic immunohistochemical study with bacteriologic correlates. Meyer PR; Shum TK; Becker TS; Taylor CR Arch Pathol Lab Med; 1983 Jul; 107(7):377-83. PubMed ID: 6190463 [TBL] [Abstract][Full Text] [Related]
4. [Immunologic shifts in persons from scleroma foci and scleroma morbidity]. Krasil'nikov AP; Kliavzunik NIu; Izraitel' NA; Krylov IA Zh Mikrobiol Epidemiol Immunobiol; 1966 Aug; 43(8):116-21. PubMed ID: 4240242 [No Abstract] [Full Text] [Related]
5. Results of streptomycin therapy in scleroma in the years 1966-1967. Klonowski S Pol Med Sci Hist Bull; 1970 Jan; 13(1):15-9. PubMed ID: 5414916 [No Abstract] [Full Text] [Related]
6. Experimental study in scleroma. Haroun AA; Abdel Razik I; el-Mallah ME J Egypt Public Health Assoc; 1985; 60(1-2):19-46. PubMed ID: 3915315 [No Abstract] [Full Text] [Related]
7. [Various serological findings in patients with rhinoscleroma]. Rojas O; García M; Berrón DR; Estrada-Parra S Rev Latinoam Microbiol; 1971; 13(1):59-60. PubMed ID: 5281209 [No Abstract] [Full Text] [Related]
8. B lymphocyte subsets in patients with rhinoscleroma. Fusconi M; Gallo A; De Virgilio A; Natalizi S; Greco A; Zambetti G; de Vincentiis M Otolaryngol Head Neck Surg; 2011 May; 144(5):809-14. PubMed ID: 21493362 [TBL] [Abstract][Full Text] [Related]
9. Modification of lymphocyte subsets in patients with rhinoscleroma. Fusconi M; Pulice G; Ippoliti F; Mastronicola R; Ralli G; de Vincentiis M Am J Otolaryngol; 2006; 27(6):401-5. PubMed ID: 17084224 [TBL] [Abstract][Full Text] [Related]
10. Streptococcal pyrogenic exotoxin B cleaves properdin and inhibits complement-mediated opsonophagocytosis. Tsao N; Tsai WH; Lin YS; Chuang WJ; Wang CH; Kuo CF Biochem Biophys Res Commun; 2006 Jan; 339(3):779-84. PubMed ID: 16329996 [TBL] [Abstract][Full Text] [Related]
11. Investigations on properdin activity in the mature and premature newborns with the intrauterine infection. Woytoń J; Gajewska E; Riess A; Rudnicka M Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):67-70. PubMed ID: 7149927 [TBL] [Abstract][Full Text] [Related]
12. [Serum levels of properdin, complement and thiocyanate during sodium thiocyanate administration]. Weuffen W; Reissmann G; Kramer A; Schroeder H; Prott V; Prott P Z Gesamte Hyg; 1980; 26(10):724-5. PubMed ID: 7467493 [No Abstract] [Full Text] [Related]
13. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. Wirthmueller U; Dewald B; Thelen M; Schäfer MK; Stover C; Whaley K; North J; Eggleton P; Reid KB; Schwaeble WJ J Immunol; 1997 May; 158(9):4444-51. PubMed ID: 9127010 [TBL] [Abstract][Full Text] [Related]
15. [Properdin content of the blood serum in tumors and flammatory diseases of the brain]. Grinberg SA Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):857-8. PubMed ID: 5050042 [No Abstract] [Full Text] [Related]
16. [Properdin in the course of diseases in hypotreptic infants]. Pawlicka-Domańska Z Ann Acad Med Stetin; 1966; 12():529-43. PubMed ID: 5921241 [No Abstract] [Full Text] [Related]
17. Human liver-derived HEP G2 cells produce functional properdin. Maves KK; Weiler JM J Lab Clin Med; 1994 Dec; 124(6):837-42. PubMed ID: 7798798 [TBL] [Abstract][Full Text] [Related]
18. The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling. Sun Z; Reid KB; Perkins SJ J Mol Biol; 2004 Nov; 343(5):1327-43. PubMed ID: 15491616 [TBL] [Abstract][Full Text] [Related]
19. [Close-focus roentgen therapy of patients with scleroma of the vestibule of the nose]. BYTCHENKO DA; GUREVICH EL Vestn Otorinolaringol; 1960; 22():87-8. PubMed ID: 13689612 [No Abstract] [Full Text] [Related]
20. The effects of heat, pH and chemical agents on the functional activity of properdin. Minta JO; Vetvutanapibul W Immunochemistry; 1978 Feb; 15(2):93-6. PubMed ID: 24582 [No Abstract] [Full Text] [Related] [Next] [New Search]